Patents by Inventor Simon Lucas

Simon Lucas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Device Control for a Communication Session
    Publication number: 20180359289
    Abstract: Techniques for device control for a communication session are described. According to various embodiments, a claim process is performed that establishes a control relationship between a controller and a remote device. The controller causes the remote device to initiate a communication session with a different device using a designated identity. The device outputs a media stream that includes session media exchanged as part of the communication session.
    Type: Application
    Filed: August 14, 2018
    Publication date: December 13, 2018
    Applicant: Microsoft Technology Licensing, LLC
    Inventors: Hamish Rory Barjonas, Simon Lucas, Carl David Blundell, Mark Christopher Wass
  • Endpoint control for a communication session
    Patent number: 10091252
    Abstract: Techniques for endpoint control for a communication session are described. According to various embodiments, a claim process is performed that establishes a control relationship between a controller and an endpoint device. The controller then causes the endpoint device to initiate a communication session with a different endpoint device using an identity of the controller. The endpoint device outputs a media stream that includes session media exchanged as part of the communication session.
    Type: Grant
    Filed: April 10, 2015
    Date of Patent: October 2, 2018
    Assignee: MICROSOFT TECHNOLOGY LICENSING, LLC
    Inventors: Hamish Rory Barjonas, Simon Lucas, Carl David Blundell, Mark Christopher Wass
  • Treatment and/or prophylaxis of TSPO mediated diseases and/or disorders
    Patent number: 9775843
    Abstract: The invention relates to certain compounds for the use in the treatment and/or prophylaxis of diseases and/or disorders that are, at least partially, mediated by TSPO activity.
    Type: Grant
    Filed: October 11, 2013
    Date of Patent: October 3, 2017
    Assignee: GRÜNENTHAL GMBH
    Inventors: Petra Bloms-Funke, Gregor Bahrenberg, Wolfgang Schröder, Sven Kühnert, Simon Lucas
  • Treatment and/or prophylaxis of TSPO mediated diseases and/or disorders
    Publication number: 20170273970
    Abstract: The invention relates to certain compounds for the use in the treatment and/or prophylaxis of diseases and/or disorders that are, at least partially, mediated by TSPO activity.
    Type: Application
    Filed: June 14, 2017
    Publication date: September 28, 2017
    Applicant: GRÜNENTHAL GMBH
    Inventors: Petra BLOMS-FUNKE, Gregor Bahrenberg, Wolfgang Schröder, Sven Kühnert, Simon Lucas
  • Snapshot capture for a communication session
    Patent number: 9509741
    Abstract: Techniques for snapshot capture for a communication session are described. According to various embodiments, a communication session is established that includes a video feed that is streamed between devices involved in the communication session. The video feed is sampled to extract still images (e.g., frames) from the video feed that include images of a particular participant in the communication session. A snapshot is then selected from the images based on one or more selection criteria, such as an image score for the snapshot. Should a quality of the video feed fall below an acceptable video quality threshold during the communication session, the snapshot is used in place of the video feed for a visual representation of the participant during the communication session.
    Type: Grant
    Filed: April 10, 2015
    Date of Patent: November 29, 2016
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Hamish Rory Barjonas, Simon Lucas, Carl David Blundell, Mark Christopher Wass
  • Snapshot Capture for a Communication Session
    Publication number: 20160301727
    Abstract: Techniques for snapshot capture for a communication session are described. According to various embodiments, a communication session is established that includes a video feed that is streamed between devices involved in the communication session. The video feed is sampled to extract still images (e.g., frames) from the video feed that include images of a particular participant in the communication session. A snapshot is then selected from the images based on one or more selection criteria, such as an image score for the snapshot. Should a quality of the video feed fall below an acceptable video quality threshold during the communication session, the snapshot is used in place of the video feed for a visual representation of the participant during the communication session.
    Type: Application
    Filed: April 10, 2015
    Publication date: October 13, 2016
    Inventors: Hamish Rory Barjonas, Simon Lucas, Carl David Blundell, Mark Christopher Wass
  • Endpoint Control for a Communication Session
    Publication number: 20160301719
    Abstract: Techniques for endpoint control for a communication session are described. According to various embodiments, a claim process is performed that establishes a control relationship between a controller and an endpoint device. The controller then causes the endpoint device to initiate a communication session with a different endpoint device using an identity of the controller. The endpoint device outputs a media stream that includes session media exchanged as part of the communication session.
    Type: Application
    Filed: April 10, 2015
    Publication date: October 13, 2016
    Inventors: Hamish Rory Barjonas, Simon Lucas, Carl David Blundell, Mark Christopher Wass
  • Specific carboxamides as KCNQ2/3 modulators
    Patent number: 9284286
    Abstract: The invention relates to specific carboxamides, to processes for their preparation, to medicaments comprising these compounds and to the use of these compounds in the preparation of medicaments.
    Type: Grant
    Filed: November 27, 2013
    Date of Patent: March 15, 2016
    Assignee: GRÜNENTHAL GMBH
    Inventors: Simon Lucas, Sven Kühnert, Gregor Bahrenberg, Wolfgang Schröder
  • Substituted 6-amino-nicotinamides as KCNQ2/3 modulators
    Patent number: 9278103
    Abstract: Substituted 6-amino-nicotinamides, pharmaceutical compositions containing these compounds and also use of these compounds in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
    Type: Grant
    Filed: March 31, 2014
    Date of Patent: March 8, 2016
    Assignee: GRÜNENTHAL GMBH
    Inventors: Sven Kühnert, Gregor Bahrenberg, Achim Kless, Wolfgang Schröder, Simon Lucas
  • Heteroquinoline-3-carboxamides as KCNQ2/3 modulators
    Patent number: 9248122
    Abstract: The invention relates to substituted heteroquinoline-3-carboxamides, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
    Type: Grant
    Filed: November 27, 2013
    Date of Patent: February 2, 2016
    Assignee: GRÜNENTHAL GMBH
    Inventors: Sven Kühnert, Simon Lucas, Gregor Bahrenberg, Wolfgang Schröder
  • Substituted 6-amino-nicotinamides as KCNQ2/3 modulators
    Patent number: 9168259
    Abstract: Substituted 6-amino-nicotinamides, pharmaceutical compositions containing these compounds and also use of these compounds in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
    Type: Grant
    Filed: April 18, 2012
    Date of Patent: October 27, 2015
    Assignee: GRÜNENTHAL GMBH
    Inventors: Sven Kühnert, Gregor Bahrenberg, Achim Kless, Wolfgang Schröder, Simon Lucas
  • TREATMENT AND/OR PROPHYLAXIS OF TSPO MEDIATED DISEASES AND/OR DISORDERS
    Publication number: 20150290203
    Abstract: The invention relates to certain compounds for the use in the treatment and/or prophylaxis of diseases and/or disorders that are, at least partially, mediated by TSPO activity.
    Type: Application
    Filed: October 11, 2013
    Publication date: October 15, 2015
    Applicant: GRÜNENTHAL GMBH
    Inventors: Petra Bloms-Funke, Gregor Bahrenberg, Wolfgang Schröder, Sven Kühnert, Simon Lucas
  • Substituted 4-aminobenzamides as KCNQ2/3 modulators
    Patent number: 9108936
    Abstract: Substituted 4-aminobenzamides, pharmaceutical compositions containing these compounds and also methods of using these compounds in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
    Type: Grant
    Filed: April 18, 2013
    Date of Patent: August 18, 2015
    Assignee: GRUENENTHAL GMBH
    Inventors: Gregor Bahrenberg, Sven Kuehnert, Simon Lucas, Wolfgang Schroeder
  • 6-pyridin-3-yl-3,4-dihydro-1h-quinolin-2-one derivatives and related compounds as inhibitors of the human aldosterone synthase CYP11B2
    Patent number: 8685960
    Abstract: The invention provides compounds of the general formula (I) which are inhibitors of the human aldosterone synthase, and also pharmaceutical compositions containing these compounds, and the use of these compounds and other heteroaryl substituted quinolinone derivatives for the treatment of hyperaldosteronism and/or disorders or diseases that are mediated by 11 ?-hydroxylase (CYP11 B1).
    Type: Grant
    Filed: May 5, 2009
    Date of Patent: April 1, 2014
    Assignee: Elexopharm GmbH
    Inventors: Rolf W. Hartmann, Ralf Heim, Simon Lucas
  • Substituted 6-amino-nicotinamides as KCNQ2/3 modulators
    Patent number: 8552200
    Abstract: Substituted 6-amino-nicotinamides, pharmaceutical compositions containing these compounds and also use of these compounds in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
    Type: Grant
    Filed: October 19, 2011
    Date of Patent: October 8, 2013
    Assignee: Gruenenthal GmbH
    Inventors: Sven Kühnert, Gregor Bahrenberg, Achim Kless, Wolfgang Schröder, Simon Lucas
  • Inhibitors of the human aldosterone synthase CYP11B2
    Patent number: 8541404
    Abstract: The invention provides compounds of the general formula (I) which are inhibitors of the human aldosterone synthase, and also pharmaceutical compositions containing these compounds, and a method of treating of hyperaldosteronism and/or disorders or diseases that are mediated by 11?-hydroxylase (CYP11B1) with these compounds.
    Type: Grant
    Filed: November 3, 2010
    Date of Patent: September 24, 2013
    Assignee: ElexoPharm GmbH
    Inventors: Rolf W. Hartmann, Ralf Heim, Simon Lucas
  • SUBSTITUTED 6-AMINO-NICOTINAMIDES AS KCNQ2/3 MODULATORS
    Publication number: 20120258947
    Abstract: Substituted 6-amino-nicotinamides, pharmaceutical compositions containing these compounds and also use of these compounds in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
    Type: Application
    Filed: April 18, 2012
    Publication date: October 11, 2012
    Applicant: Grunenthal GmbH
    Inventors: Sven KÜHNERT, Gregor Bahrenberg, Achim Kless, Wolfgang Schröder, Simon Lucas
  • SUBSTITUTED 6-AMINO-NICOTINAMIDES AS KCNQ2/3 MODULATORS
    Publication number: 20120101079
    Abstract: Substituted 6-amino-nicotinamides, pharmaceutical compositions containing these compounds and also use of these compounds in the treatment and/or prophylaxis of pain and further diseases and/or disorders.
    Type: Application
    Filed: October 19, 2011
    Publication date: April 26, 2012
    Applicant: Grunenthal GmbH
    Inventors: Sven Kühnert, Gregor Bahrenberg, Achim Kless, Wolfgang Schröder, Simon Lucas
  • 6-Pyridin-3-YL-3,4-Dihydro-1H-Quinolin-2-One Derivatives and Related Compounds as Inhibitors of the Human Aldosterone Synthase CYP11B2
    Publication number: 20110118241
    Abstract: The invention provides compounds of the general formula (I) which are inhibitors of the human aldosterone synthase, and also pharmaceutical compositions containing these compounds, and the use of these compounds and other heteroaryl substituted quinolinone derivatives for the treatment of hyperaldosteronism and/or disorders or diseases that are mediated by 11 ?-hydroxylase (CYP11 B1).
    Type: Application
    Filed: May 5, 2009
    Publication date: May 19, 2011
    Applicant: Universitat des Saarlandes
    Inventors: Rolf W. Hartmann, Ralf Heim, Simon Lucas
  • Inhibitors of the Human Aldosterone Sythase CYP11B2
    Publication number: 20110112067
    Abstract: The invention provides compounds of the general formula (I) which are inhibitors of the human aldosterone synthase, and also pharmaceutical compositions containing these compounds, and a method of treating of hyperaldosteronism and/or disorders or diseases that are mediated by 11?-hydroxylase (CYP11B1) with these compounds.
    Type: Application
    Filed: November 3, 2010
    Publication date: May 12, 2011
    Applicant: Universitat des Saarlandes
    Inventors: Rolf W. Hartmann, Ralf Heim, Simon Lucas